The treatment involves implanting a device called Remede. Michael Newnam, MD, director of sleep medicine at the Oklahoma Heart Institute within the medical center, said the therapy isn’t for obstructive sleep apnea patients.
“Where we see central sleep apnea predominantly are in folks who have heart failure or other cardiovascular conditions,” Dr. Newnam told News9. “We will sometimes see it in people who have a stroke or people who have rhythms.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
